RUNX2 Represses the EWS-FLI1-mediated Transcription in Ewing’s Sarcoma Cells

Cancer Genomics and Proteomics · Published 2026-01-01 · DOI 10.21873/cgp.20559

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.21873/cgp.20559

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Differential Proteomic Analysis of DEN-induced Hepatocellular Carcinoma in Male and Female Balb/c Mice Reveals Novel Sex-Specific Markers · Cancer Genomics and Proteomics · 2025 · Same journal
• Global Profiling of Lysine Lactylation in Prostate Cancer Cells · Cancer Genomics and Proteomics · 2025 · Same journal
• Proteomic Signatures of Cellular Reprogramming in Bladder Cancer: Insights into the Acquisition of Cancer Stem-like States and Phenotypic Plasticity · Cancer Genomics and Proteomics · 2026 · Same journal
• Immunoliposome for Ewing Sarcoma · Cancer Genomics and Proteomics · 2025 · Same journal
• Timescale-dependent Phosphoproteomic Remodeling and Motility-associated Adaptation under Chronic Cabozantinib Exposure in Renal Cell Carcinoma · Cancer Genomics and Proteomics · 2026 · Same journal
• Angiogenic Edge of ANGPT2: Genetic Variants Shape Prostate Cancer Prognosis on Androgen Deprivation Therapy · Cancer Genomics and Proteomics · 2025 · Same journal
• Effects of Isthmus Topography on the Molecular Characteristics of BRAF -mutant Papillary Thyroid Cancer · Cancer Genomics and Proteomics · 2026 · Same journal
• Mechanistic Insights into Threonine Tyrosine Kinase Mediated Cell Cycle Regulation in Triple-negative Breast Cancer · Cancer Genomics and Proteomics · 2026 · Same journal
• Co-expression of PKCζ and ALDH1A3 Is Associated With Poor Chemotherapeutic Responses in Basal-like Breast Cancer · Cancer Genomics and Proteomics · 2026 · Same journal
• Myxoid Pleomorphic Liposarcoma: A Review and Update · Cancer Genomics and Proteomics · 2026 · Same journal